NOVO NORDISK INC.

Lobbying for NOVO NORDISK INC.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Expenses

$2,010,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

ANSLEY RHYNE

Previously held: Legislative Assistant, Sen. Marco Rubio
ROSALYN KUMAR New on this filing

Previously held: Deputy Chief of Staff, Rep. Debbie Wasserman Schultz; Tax Counsel, Senator Stabenow

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 11

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Medicare/Medicaid

Obesity, Treat and Reduce Obesity Act, IRA implementation, General engagement around drug pricing.

S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, Safe Drugs Act and Pharmaceutical Compounding.

Taxation/Internal Revenue Code

International and corporate tax issues.

Tariff (miscellaneous tariff bills)

Tariffs and trade policy.

Health Issues

Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation and drug pricing legislation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, Safe Drugs Act and Pharmaceutical Compounding.

Budget/Appropriations

Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, Safe Drugs Act and Pharmaceutical Compounding, FDA Agricultural Appropriations bill.

Bills named in this filing 1

S. 150
Affordable Prescriptions for Patients Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.